Key Considerations for Improving Dosage Optimization in Oncology
A series published in the AACR journal Clinical Cancer Research shared key considerations for improving dosage optimization in oncology.
Tag: FDA workshops
A series published in the AACR journal Clinical Cancer Research shared key considerations for improving dosage optimization in oncology.
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
When the chemotherapy drug 5-fluorouracil (5-FU) was approved in 1962, there was limited understanding of how it is metabolized...
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
On September 6, 2018, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research hosted...
“We are in a promising time for cancer research and treatment; however, ovarian cancer remains difficult to treat, since...